BioSpace News Archive

International Isotopes Inc. Announces Exclusive Licensing Agreement For Commercialization Of A Radiolabled Antibody Test For Detecting SARS CoV-2

International Isotopes Inc. (OTCQB: INIS) (“International Isotopes” or “INIS”) is pleased to announce updated information regarding research it has been funding towards an advanced disease testing procedure for SARS CoV-2, the virus responsible for the COVID pandemic.

December 7, 2021
·
5 min read
Drug Development

HiberCell To Present New Data on Odetiglucan Plus Pembrolizumab in Ongoing Phase 2 Metastatic Breast Cancer Trial at San Antonio Breast Cancer Symposium

HiberCell will present new data from the ongoing phase 2 open-label clinical trial evaluating the company’s odetiglucan (Imprime PGG) at the 2021 San Antonio Breast Cancer Symposium (SABCS) from December 7-10, 2021.

December 7, 2021
·
2 min read
Deals

I-Mab to Pursue Dual Listing Plan on The Main Board of The Stock Exchange of Hong Kong Limited

I-Mab today announced that the Board of Directors of the Company (the “Board”) approved a motion to pursue the listing of the Company’s ordinary shares on The Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Dual Listing”).

December 7, 2021
·
4 min read
Business

Persephone Biosciences Announces Collaboration with Janssen for Colorectal Arm of ARGONAUT Study

Persephone Biosciences Inc. today announced a collaboration with Janssen Research & Development, LLC, (Janssen) for the colorectal cancer (CRC) arm of Persephone’s ARGONAUT study.

December 7, 2021
·
3 min read
MedAvail to Present at the Lytham Partners Winter 2021 Investor Conference

MedAvail Holdings, Inc. today announced that the company will be participating in the upcoming Lytham Partners Winter 2021 Investor Conference.

December 7, 2021
·
1 min read
Business

Pharvaris Announces Changes to its Board of Directors

Pharvaris today announced the appointment of Elisabeth Björk, M.D., to the board of directors with expected confirmation at the company’s 2022 annual general meeting of shareholders.

December 7, 2021
·
5 min read
Biotech Bay

Inscopix’s nVue System for Brain Mapping Named Innovation of the Year by The Scientist

Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that its dual color miniscope imaging technology, the nVue™ System, has been named the top innovation for 2021 by The Scientist Magazine based on an independent review from a team of esteemed judges.

December 7, 2021
·
3 min read
Biotech Bay

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

Fluidigm Corporation today confirmed that Omicron variant B.1.1.529, designated by the World Health Organization as a Variant of Concern, does not impact the capability of the Fluidigm® Advanta™ Dx SARS-CoV-2 RT-PCR Assay to detect the virus that causes COVID-19.

December 7, 2021
·
5 min read
Business

Delix Therapeutics Partners with the National Institute on Drug Abuse (NIDA) to Advance Research on Non-Hallucinogenic Therapies to Treat Substance Use Disorders

Delix Therapeutics today announced a partnership with The National Institute on Drug Abuse (NIDA), a federal scientific research institute under the U.S. Department of Health and Human Services’ National Institutes of Health (NIH).

December 7, 2021
·
3 min read
Biotech Bay

PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patients

PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases.

December 7, 2021
·
3 min read